Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Strenger, V.
It happens every year, but every year it's different. An influenza update
PADIATR PADOL. 2017; 52(6): 245-250. Doi: 10.1007/s00608-017-0524-7
Web of Science FullText FullText_MUG

Leading authors Med Uni Graz: Strenger Volker
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: In contrast to mild flu-like illnesses, which are caused by numerous viruses, the genuine influenza virus may cause severe infections with high fevers, cough, sore throat and body aches, in addition to complications such as pneumonia, encephalitis, myocarditis and acute otitis media. The influenza season usually starts in the new year and lasts for 2-3 months, infecting 5-20% of the population. Although the rate of infections and hospitalisations is particularly high among toddlers, the influenza-associated mortality rate (approximately 1,000 deaths per year in Austria) mainly affects persons > 65 years of age. In Austria, annual influenza vaccination is recommended for all persons older than 6 months of age. Children younger than 8 years of age vaccinated for the first time should receive a second shot at least 4 weeks after the first. Vaccines are adapted every year according to the circulating strains. Tri- and tetravalent inactivated influenza vaccines (IIV) are available, in addition to a tetravalent live attenuated influenza vaccine (LAIV), approved for children and adolescents since 2014, which is administered intranasally. Comparative studies of the various vaccine types show conflicting results. Therefore, a definite recommendation with regard to which vaccine type to use is not possible at the moment.
Find related publications in this database (Keywords): Influenza; Flu-like illness; Neuraminidase inhibitor; Intranasal vaccine; Tetravalent vaccine